Aristotle University Of Thessaloniki (AUTH)
Μελέτη μοριακής ανίχνευσης των ιών Epstein-Barr και λευχαιμίας των βοοειδών σε δείγματα αναρρόφησης δια λεπτής βελόνης ασθενών με καρκίνο του μαστού
Abstract
dc:descriptionViral carcinogenesis has been extensively investigated as a potential contributor in breast cancer development. Among the infectious agents im-plicated, Bovine Leukemia Virus (BLV) and Epstein–Barr Virus (EBV) have received considerable attention. However, existing evidence regarding their involvement in breast carcinogenesis remains inconclusive and inconsistent across studies. The aim of this prospective case-control study was to investigate the molecular detection of EBV and BLV genetic material in breast fine-needle aspiration (FNA) samples obtained from patients with breast cancer and healthy controls and to evaluate potential associations of their presence with specific clinicoepidemiological and histopathological factors. Cytological FNA samples were collected under ultrasound guidance from histologically confirmed malignant breast lesions of 52 patients with breast cancer and from clinically radiologically normal breast tissue of 52 healthy women without previous or present breast diseases. Participants were recruited at the 2nd Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki. Detection of EBV and BLV genetic material was performed using real-time polymerase chain reaction (real-time PCR) assays. Primary outcomes were the comparisons of detection frequencies of EBV and BLV genetic material between breast cancer cases and healthy controls. Secondary outcomes comprised the assessment of associations between the molecular detection of each virus and selected epidemiological, clinical, and histopathological characteristics of the study participants. To our knowledge, this represents the first study investigating the molecular detection of EBV and BLV genetic material in breast cytological samples obtained from a Greek population. EBV genetic material was detected in FNA cytological specimens from 4 of 52 breast cancer patients (7.7%) and 1 of 52 healthy controls (1.9%). In contrast, BLV genetic material was not detected in any sample, either among breast cancer patients (0/52) or healthy controls (0/52). Although EBV positivity was approximately four-fold more common among breast cancer patients, the difference did not reach statistical significance (OR=4.25, 95% CI 0.46-39.4, p=0.363). Among breast cancer cases, EBV molecular detection was significantly associated with less favorable clinicopathological characteristics, mainly HER2 overexpression, advanced preoperative disease stage and lymph node metastasis. The findings of the present study do not support a statistically significant association between EBV or BLV infection and breast cancer development in this Greek population. However, the higher prevalence of EBV molecular detection among breast cancer patients compared to healthy controls may indicate a possible association between the infection of breast cells by EBV and development of breast cancer that warrants further investigation. Further large-scale studies are required to further elucidate the contribution of viral infection to the pathophysiology of breast cancer.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Margioula-Siarkou, Georgia
- Μαργιούλα-Σιάρκου, Γεωργία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62832